|
|
||||||||
-'opiate' receptors in the motor effects of antipsychotic drugs
From the Department of Psychology and Division of Biology and Medicine (Dr. J. M. Walker, Ms. Matsumoto, Dr. Bowen, Ms. Gans, and Mr. Jones), Brown University, Providence, RI; and the Department of Neurology (Dr. F. O. Walker), Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.
Haloperidol exhibits a high affinity for a subclass of
-"opiate" binding sites which have a unique anatomic distribution and a unique drug selectivity pattern. These binding sites differ from phencyclidine-sensitive
-receptors and are found in many brain areas involved in the control of movement. 1,3-Di-o-tolylguanidine (DTG), a highly selective ligand for the haloperidol-sensitive
-receptor, produced marked dystonia in rats after micro injection into the red nucleus, a motor area rich in this receptor. Haloperidol and another
-ligand [(+)-SKF 10,047] produced similar effects. On the other hand, clozapine, an antipsychotic drug which fails to bind to
-receptors and fails to induce movement disorders in humans, failed to induce these dystonic reactions in rats. Phencyclidine was also without effect, as were injections of the active compounds in sites distant to the red nucleus. Microinjections of DTG in the substantia nigra produced vigorous contralateral circling behavior at extremely low doses. These findings suggest that
-binding sites represent biologically functional receptors that are active in the neural control of movement. Since haloperidol (and many other antipsychotic drugs) exhibit an affinity for
-receptors which is at least equal to its affinity for dopamine receptors, these data raise the further possibility that
-receptors are involved in the motor side effects of antipsychotic drugs.
Address correspondence and reprint requests to Dr. J. M. Walker, Walter S. Hunter Laboratory of Psychology, Brown University, Box 1853, Providence, RI 02912.
Supported by the Dystonia Medical Research Foundation, The Rhode Island Foundation, the Public Health Service (NS21745, DA07736), and Brown University.
Received July 2, 1987. Accepted for publication in final form October 15, 1987.
This article has been cited by other articles:
![]() |
C. E. Pizoli, H. A. Jinnah, M. L. Billingsley, and E. J. Hess Abnormal Cerebellar Signaling Induces Dystonia in Mice J. Neurosci., September 1, 2002; 22(17): 7825 - 7833. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Janavs and M. J Aminoff Dystonia and chorea in acquired systemic disorders J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 436 - 445. [Full Text] |
||||
![]() |
C. Cohen, D. J. Sanger, and G. Perrault Characterization of the Discriminative Stimulus Produced by the Dopamine Antagonist Tiapride J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 566 - 573. [Abstract] [Full Text] |
||||
![]() |
B.E. Leonard and C.D. Nicholson Sigma ligands as potential psychotropic drugs J Psychopharmacol, January 1, 1994; 8(1): 64 - 65. [PDF] |
||||
![]() |
S Schwarz, P Pohl, and G. Zhou Steroid binding at sigma-"opioid" receptors Science, December 22, 1989; 246(4937): 1635 - 1637. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |